Larson Financial Group
WVE icon

Larson Financial Group’s Wave Life Sciences WVE Stock Holding History

Larson Financial Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.04K Sell
281
-1,027
-79% -$5.4K ﹤0.01% 3409
2026
Q2 		$7.6K Sell
1,308
-775
-37% -$5.14K ﹤0.01% 2562
2026
Q1 		$15.1K Buy
2,083
+1,241
+147% +$16.2K ﹤0.01% 2003
2025
Q4 		$14.3K Buy
842
+150
+22% +$1.52K ﹤0.01% 1916
2025
Q3 		$5.06K Sell
692
-736
-52% -$5.96K ﹤0.01% 2349
2025
Q2 		$9.28K Buy
1,428
+586
+70% +$3.87K ﹤0.01% 1845
2025
Q1 		$6.8K Buy
+842
New +$9.21K ﹤0.01% 1782

Other funds holding WVE

GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Larson Financial Group's WVE Position: Q3 2026 in Review

Larson Financial Group reduced its Wave Life Sciences (WVE) stake by 79% in Q3 2026, selling an estimated $5.4K and leaving 281 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.

Larson Financial Group first reported a position in WVE in Q1 2025 and has held it in 7 quarters since. The position peaked at $15.1K in Q1 2026. 92 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • Larson Financial Group held 281 shares of Wave Life Sciences worth $1.04K as of Q3 2026.
  • Larson Financial Group sold 1,027 Wave Life Sciences shares in Q3 2026, an estimated $5.4K.
  • Wave Life Sciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3409 holding.
  • Larson Financial Group first reported a position in Wave Life Sciences in Q1 2025 and has held it in 7 quarters since.
  • Larson Financial Group's Wave Life Sciences position peaked at $15.1K in Q1 2026.
  • 92 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.